6fmd: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "6fmd" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 6fmd is ON HOLD | The entry 6fmd is ON HOLD until Paper Publication | ||
Authors: Goyal, P., Jarva, M., Andersson, M., Lolli, M.L., Friemann, R. | Authors: Goyal, P., Jarva, M., Andersson, M., Lolli, M.L., Friemann, R. | ||
Revision as of 05:26, 15 February 2018
Unreleased structure
The entry 6fmd is ON HOLD until Paper Publication
Authors: Goyal, P., Jarva, M., Andersson, M., Lolli, M.L., Friemann, R.
Description: Targeting myeloid differentiation using potent human dihydroorotate dehydrogenase (hDHODH) inhibitors based on 2-hydroxypyrazolo[1,5-a]pyridine scaffold
